Recent 24-Month Real-World PALADIN Data Demonstrate the Ability of ILUVIEN® to Significantly Reduce Treatment Burden in Patients with Diabetic Macular Edema
Stock Information for Daxor Corporation
Loading
Please wait while we load your information from QuoteMedia.